Ana Sayfa › Küçük Hücreli Olmayan Akciğer Kanseri › Columbia Bölgesi › Washington
Washington, DC içinde Küçük Hücreli Olmayan Akciğer Kanseri klinik çalışmaları
Küçük Hücreli Olmayan Akciğer Kanseri için 55 çalışma, Washington ve çevresindeki (yaklaşık 30 mil mesafedeki) merkezlerde katılımcı arıyor. Kimlerin katılabileceğini ve çalışma ekibine nasıl ulaşılacağını görmek için bir çalışmayı açın.
Resmi çalışma metni (İngilizce)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Katılımcı aranıyorEvre 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- ve 1 tane daha
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Katılımcı aranıyorGözlemsel çalışma
- National Institutes of Health Clinical Center, Bethesda · 7 mil uzakta
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Katılımcı aranıyorEvre 2
- Local Institution - 0183, Washington D.C.
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Katılımcı aranıyorEvre 3
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
A Study of PHN-012 in Patients With Advanced Solid Tumors
Katılımcı aranıyorEvre 1
- PHN-012-001 Site, Washington D.C.
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Katılımcı aranıyorEvre 2
- Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital, Washington D.C.
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Katılımcı aranıyorGözlemsel çalışma
- National Institutes of Health Clinical Center, Bethesda · 7 mil uzakta
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Katılımcı aranıyorEvre 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mil uzakta
- Maryland Oncology Hematology, P.A., Bethesda · 7 mil uzakta
- Maryland Oncology Hematology, P.A, Largo · 11 mil uzakta
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Katılımcı aranıyorEvre 2
- National Institutes of Health Clinical Center, Bethesda · 7 mil uzakta
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Katılımcı aranıyorEvre 3
- Research Site, Silver Spring · 7 mil uzakta
- Research Site, Bethesda · 7 mil uzakta
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Katılımcı aranıyorEvre 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mil uzakta
- Maryland Oncology Hematology, P.A., Bethesda · 7 mil uzakta
- Maryland Oncology Hematology, P.A., Largo · 11 mil uzakta
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Katılımcı aranıyorEvre 2
- MedStar Georgetown University Hospital, Washington D.C.
- Washington DC VA Medical Center, Washington D.C.
- Maryland Oncology Hematology P A, Silver Spring · 7 mil uzakta
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Katılımcı aranıyorEvre 2
- Georgetown University, Washington D.C.
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Katılımcı aranıyorEvre 3
- Washington DC Veterans Affairs Medical Center, Washington D.C.
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Katılımcı aranıyorEvre 2
- MedStar Georgetown University Hospital, Washington D.C.
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Katılımcı aranıyorEvre 3
- Sibley Memorial Hospital, Washington D.C.
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Katılımcı aranıyorEvre 1
- National Institutes of Health Clinical Center, Bethesda · 7 mil uzakta
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Katılımcı aranıyorEvre 2/3
- MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
- MEDSTAR Washington Hospital Center (MedStar Health Research Institute), Washington D.C.
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Katılımcı aranıyorEvre 1
- Georgetown University Medical Center, Washington D.C.
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Katılımcı aranıyorEvre 3
- Research Site, Bethesda · 7 mil uzakta
- Research Site, Bethesda · 7 mil uzakta
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Katılımcı aranıyorEvre 3
- George Washington University Cancer Center, Washington D.C.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Katılımcı aranıyorEvre 1/2
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Katılımcı aranıyorEvre 2/3
- Local Institution - 007-5476, Washington D.C.
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Katılımcı aranıyorEvre 2
- MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center), Washington D.C.
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Katılımcı aranıyorEvre 3
- Sibley Memorial Hospital, Washington D.C.
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Katılımcı aranıyorEvre 3
- Walter Reed National Military Medical Center, Bethesda · 7 mil uzakta
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Katılımcı aranıyorEvre 3
- Washington Hospital Center ( Site 0037), Washington D.C.
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Katılımcı aranıyorEvre 2
- National Institutes of Health Clinical Center, Bethesda · 7 mil uzakta
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Katılımcı aranıyorEvre 3
- Research Site, Bethesda · 7 mil uzakta
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Katılımcı aranıyorEvre 2
- MedStar Georgetown University Hospital, Washington D.C.
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Katılımcı aranıyorEvre 1
- Sibley Memorial Hospital, Washington D.C.
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Katılımcı aranıyorEvre 3
- Sibley Memorial Hospital, Washington D.C.
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Katılımcı aranıyorEvre 1/2
- National Institutes of Health, Bethesda · 7 mil uzakta
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Katılımcı aranıyorEvre 1/2
- Georgetown University - Lombardi Comprehensive Cancer Center, Washington D.C.
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Katılımcı aranıyorEvre 1/2
- Georgetown University Medical Center, Washington D.C.
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
Katılımcı aranıyorEvre 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Katılımcı aranıyorEvre 1/2
- Georgetown University, Washington D.C.
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Katılımcı aranıyorEvre 1
- Maryland Oncology Hematology, Calverton · 12 mil uzakta
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Katılımcı aranıyorEvre 1/2
- Georgetown University Medical Center, Washington D.C.
Gilteritinib for the Treatment of ALK NSCLC
Katılımcı aranıyorEvre 1
- Georgetown University, Washington D.C.
Study of XB010 in Subjects With Solid Tumors
Katılımcı aranıyorEvre 1
- Georgetown University Medical Center, Washington D.C.
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Katılımcı aranıyorEvre 2
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 mil uzakta
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Katılımcı aranıyorEvre 2
- USA11-0, Bethesda · 7 mil uzakta
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Katılımcı aranıyorEvre 3
- Georgetown University Medical Cener (GUMC), Washington D.C.
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Katılımcı aranıyorEvre 3
- Research Site, Washington D.C.
- Research Site, Bethesda · 7 mil uzakta
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Katılımcı aranıyorEvre 2/3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 mil uzakta
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Katılımcı aranıyorEvre 2
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 mil uzakta
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Katılımcı aranıyorEvre 1/2
- Sibley Memorial Hospital, Washington D.C.
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
Katılımcı aranıyorEvre 2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
- Medstar Washington Hospital Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Katılımcı aranıyorEvre 1
- National Cancer Institute, Bethesda · 7 mil uzakta
Repositioning Immunotherapy in VetArans With Lung Cancer
Katılımcı aranıyorEvre 2
- VA Central Office, Washington, DC, Washington D.C.
GEMINI-NSCLC: NSCLC Biomarker Study
Katılımcı aranıyorGözlemsel çalışma
- The Center for Cancer and Blood Disorder, Bethesda · 7 mil uzakta
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Katılımcı aranıyorEvre 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Katılımcı aranıyorGözlemsel çalışma
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mil uzakta
- Massive Bio SYNERGY-AI site, Bethesda · 7 mil uzakta
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
Katılımcı aranıyorEvre 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Diğer şehirlerde Küçük Hücreli Olmayan Akciğer Kanseri çalışmaları
- Houston, TX145 çalışma
- New York City, NY121 çalışma
- Arlington, VA104 çalışma
- Nashville, TN97 çalışma
- Boston, MA90 çalışma
- Los Angeles, CA87 çalışma
- St. Louis, MO73 çalışma
- Chicago, IL61 çalışma
- Baltimore, MD60 çalışma
- San Antonio, TX59 çalışma
- Columbus, OH57 çalışma
- Seattle, WA53 çalışma
Washington içinde diğer çalışmalar
- Kanser (tüm türler)58 çalışma
- Meme Kanseri46 çalışma
- Metastatik Kanser43 çalışma
- Akciğer Kanseri41 çalışma
- Prostat Kanseri38 çalışma
- Obezite33 çalışma
- Kolorektal Kanser29 çalışma
- Kardiyovasküler Hastalık28 çalışma
- Mesane Kanseri26 çalışma
- Akut Miyeloid Lösemi24 çalışma
- Yumurtalık Kanseri23 çalışma
- Lenfoma23 çalışma
ClinicalTrials.gov'dan alınmıştır, veri tarihi: 6 Eki 2026. Her çalışma kendi uygunluk kriterlerini belirler; katılım kararı çalışma ekibine aittir.